Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Value Stock, Under Radar
1147.8000 -25.10 (-2.14%)
NSE May 30, 2025 15:31 PM
Volume: 2.0M
 

logo
Aurobindo Pharma Ltd.
10 Nov 2015
1147.80
-2.14%
buy
by Phillip Capital
Target: 940
Phillip Capital
9 US sales maintained growth momentum (+26% yoy to US$ 224mn vs. estimated US$ 227mn)onincrementaltractionfromnewlaunches. 9 Its US injectable subsidiary, Aurolife, reported muted sales of US$ 10mn due to...
 
Axis Direct released a Buy report for Aurobindo Pharma Ltd. with a price target of 1500.0 on 28 May, 2025.
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - May 30, 2025
The Baseline | 30 May 2025, 05:44PM
Market closes lower, Lemon Tree Hotels' Q4 net profit beats Forecaster estimates by 13.5%
Trendlyne Marketwatch | 30 May 2025, 03:54PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020